skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: BACON - Mir@bel - GLOBAL_LIBRESACCES remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Long-Term Ibrutinib Therapy Reverses CD8 + T Cell Exhaustion in B Cell Chronic Lymphocytic Leukaemia
Long-Term Ibrutinib Therapy Reverses CD8 + T Cell Exhaustion in B Cell Chronic Lymphocytic Leukaemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-Term Ibrutinib Therapy Reverses CD8 + T Cell Exhaustion in B Cell Chronic Lymphocytic Leukaemia

Parry, Helen M ; Mirajkar, Nikhil ; Cutmore, Natasha ; Zuo, Jianmin ; Long, Heather ; Kwok, Marwan ; Oldrieve, Ceri ; Hudson, Chris ; Stankovic, Tatjana ; Paneesha, Shankara ; Kelly, Melanie ; Begum, Jusnara ; McSkeane, Tina ; Pratt, Guy ; Moss, Paul

Frontiers in immunology, 2019-12, Vol.10, p.2832 [Periódico revisado por pares]

Switzerland: Frontiers Research Foundation

Texto completo disponível

Citações Citado por
2
Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer

Avanzato, Victoria A. ; Matson, M. Jeremiah ; Seifert, Stephanie N. ; Pryce, Rhys ; Williamson, Brandi N. ; Anzick, Sarah L. ; Barbian, Kent ; Judson, Seth D. ; Fischer, Elizabeth R. ; Martens, Craig ; Bowden, Thomas A. ; de Wit, Emmie ; Riedo, Francis X. ; Munster, Vincent J.

Cell, 2020-12, Vol.183 (7), p.1901-1912.e9 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma

Ching, Travers ; Duncan, Megan E ; Newman-Eerkes, Tera ; McWhorter, Mollie M E ; Tracy, Jeffrey M ; Steen, Michelle S ; Brown, Ryan P ; Venkatasubbarao, Srivatsa ; Akers, Nicholas K ; Vignali, Marissa ; Moorhead, Martin E ; Watson, Drew ; Emerson, Ryan O ; Mann, Tobias P ; Cimler, B Melina ; Swatkowski, Pamela L ; Kirsch, Ilan R ; Sang, Charles ; Robins, Harlan S ; Howie, Bryan ; Sherwood, Anna

BMC cancer, 2020-06, Vol.20 (1), p.612-15, Article 612 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group
Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group

Winqvist, Maria ; Asklid, Anna ; Andersson, P O ; Karlsson, Karin ; Karlsson, Claes ; Lauri, Birgitta ; Lundin, Jeanette ; Mattsson, Mattias ; Norin, Stefan ; Sandstedt, Anna ; Hansson, Lotta ; Österborg, Anders

Haematologica (Roma), 2016-12, Vol.101 (12), p.1573-1580 [Periódico revisado por pares]

Italy: Ferrata Storti Foundation

Texto completo disponível

Citações Citado por
5
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptor
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptor
Material Type:
Artigo 		Adicionar ao Meu Espaço

Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptor

Maffei, Rossana ; Bulgarelli, Jenny ; Fiorcari, Stefania ; Martinelli, Silvia ; Castelli, Ilaria ; Valenti, Vanessa ; Rossi, Davide ; Bonacorsi, Goretta ; Zucchini, Patrizia ; Potenza, Leonardo ; Vallisa, Daniele ; Gattei, Valter ; Del Poeta, Giovanni ; Forconi, Francesco ; Gaidano, Gianluca ; Narni, Franco ; Luppi, Mario ; Marasca, Roberto Rishi, Arun

PloS one, 2014-06, Vol.9 (6), p.e98818-e98818 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por
6
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
Material Type:
Artigo 		Adicionar ao Meu Espaço

T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers

Palma, Marzia ; Gentilcore, Giusy ; Heimersson, Kia ; Mozaffari, Fariba ; Näsman-Glaser, Barbro ; Young, Emma ; Rosenquist, Richard ; Hansson, Lotta ; Österborg, Anders ; Mellstedt, Håkan

Haematologica (Roma), 2017-03, Vol.102 (3), p.562-572 [Periódico revisado por pares]

Italy: Ferrata Storti Foundation

Texto completo disponível

Citações Citado por
7
Ibrutinib for relapsed/refractory chronic lymphocytic leukemia: a UK and Ireland analysis of outcomes in 315 patients
Ibrutinib for relapsed/refractory chronic lymphocytic leukemia: a UK and Ireland analysis of outcomes in 315 patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ibrutinib for relapsed/refractory chronic lymphocytic leukemia: a UK and Ireland analysis of outcomes in 315 patients

Haematologica (Roma), 2016-12, Vol.101 (12), p.1563-1572 [Periódico revisado por pares]

Italy: Ferrata Storti Foundation

Texto completo disponível

Citações Citado por
8
Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia
Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia

Shapiro, Mika ; Herishanu, Yair ; Katz, Ben-Zion ; Dezorella, Nili ; Sun, Clare ; Kay, Sigi ; Polliack, Aaron ; Avivi, Irit ; Wiestner, Adrian ; Perry, Chava

Haematologica (Roma), 2017-05, Vol.102 (5), p.874-882 [Periódico revisado por pares]

Italy: Ferrata Storti Foundation

Texto completo disponível

Citações Citado por
9
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia

Giménez, Neus ; Martínez-Trillos, Alejandra ; Montraveta, Arnau ; Lopez-Guerra, Mónica ; Rosich, Laia ; Nadeu, Ferran ; Valero, Juan G ; Aymerich, Marta ; Magnano, Laura ; Rozman, Maria ; Matutes, Estella ; Delgado, Julio ; Baumann, Tycho ; Gine, Eva ; González, Marcos ; Alcoceba, Miguel ; Terol, M José ; Navarro, Blanca ; Colado, Enrique ; Payer, Angel R ; Puente, Xose S ; López-Otín, Carlos ; Lopez-Guillermo, Armando ; Campo, Elias ; Colomer, Dolors ; Villamor, Neus

Haematologica (Roma), 2019-03, Vol.104 (3), p.576-586 [Periódico revisado por pares]

Italy: Ferrata Storti Foundation

Texto completo disponível

Citações Citado por
10
Venetoclax penetrates in cerebrospinal fluid and may be effective in chronic lymphocytic leukemia with central nervous system involvement
Venetoclax penetrates in cerebrospinal fluid and may be effective in chronic lymphocytic leukemia with central nervous system involvement
Material Type:
Artigo 		Adicionar ao Meu Espaço

Venetoclax penetrates in cerebrospinal fluid and may be effective in chronic lymphocytic leukemia with central nervous system involvement

Reda, Gianluigi ; Cassin, Ramona ; Dovrtelova, Gabriela ; Matteo, Cristina ; Giannotta, Juri ; D'Incalci, Maurizio ; Cortelezzi, Agostino ; Zucchetti, Massimo

Haematologica (Roma), 2019-05, Vol.104 (5), p.e222-e223 [Periódico revisado por pares]

Italy: Ferrata Storti Foundation

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (11.941)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (11.996)
  2. Reports  (12)
  3. Anais de Congresso  (6)
  4. Resenhas  (6)
  5. Mais opções open sub menu

Assunto 

  1. Science & Technology  (10.437)
  2. Life Sciences & Biomedicine  (8.234)
  3. Humans  (5.706)
  4. Cancer  (3.896)
  5. Review  (3.469)
  6. Leukemia  (3.407)
  7. Proteins  (3.214)
  8. Oncology  (2.778)
  9. Tumors  (2.725)
  10. Apoptosis  (2.695)
  11. Gene Expression  (2.648)
  12. Kinases  (2.464)
  13. Lymphoma  (2.400)
  14. Science & Technology - Other Topics  (2.149)
  15. Multidisciplinary Sciences  (2.116)
  16. Lymphocytes  (2.074)
  17. Patients  (2.015)
  18. Health Aspects  (2.011)
  19. Biochemistry & Molecular Biology  (1.989)
  20. Hematology  (1.980)
  21. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1981  (34)
  2. 1981Até1990  (130)
  3. 1991Até2000  (204)
  4. 2001Até2011  (1.358)
  5. Após 2011  (10.295)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (12.000)
  2. Japonês  (1.571)
  3. Italiano  (28)
  4. Norueguês  (26)
  5. Francês  (22)
  6. Português  (14)
  7. Russo  (12)
  8. Alemão  (1)
  9. Espanhol  (1)
  10. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.